13G Filing: Stonepine Capital Management, LLC Details Ownership of Vanda Pharmaceuticals Inc. (VNDA)

Page 7 of 8 SEC Filing

Item 3. If this statement is
filed pursuant to rule 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a) [ ] Broker or dealer registered
under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section
3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as
defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered
under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser
in accordance with section 240.13d-1(b)(1)(ii)(E). As to the General Partner.

(f) [ ] An employee benefit plan
or endowment fund in accordance with section 240.13d-1(b)(1)(ii)(F).

(g) [] A parent holding
company or control person in accordance with 240.13d-1(b)(1)(ii)(G). As to Mr. Plexico and Mr. Lynch.

(h) [ ] A savings association
as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

(i) [ ] A church plan that is
excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

(j) [ ] A non-U.S. institution
in accordance with §240.13d-1(b)(ii)(J).

(k) [ ] Group, in accordance
with Rule 13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution
in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution _______________________________________________________________.

Item 4. Ownership.

See Page 1 and Items 5-9 and 11 of the cover page for each Filer.

Item 5. Ownership of Five Percent
or Less of a Class

If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check
the following [ X ].

Item 6. Ownership of More than
Five Percent on Behalf of Another Person.

The Fund holds the Stock for the benefit of its investors and has
the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Stock.

Item 7. Identification and Classification
of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification
of Members of the Group.

The General Partner is the general partner
and investment adviser of the Fund. Mr. Plexico and Mr. Lynch are the control persons of the General Partner. The Filers are filing
this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each Filer also disclaims beneficial
ownership of the Stock except to the extent of that person’s pecuniary interest therein. In addition, the filing of this
Schedule 13G on behalf of the Fund should not be construed as an admission that it is, and it disclaims that it is, a beneficial
owner, as defined in Rule 13d-3 under the Act, of any of the Stock covered by this Schedule 13G.

Item 9. Notice of Dissolution
of Group

Not applicable.

Item 10. Material to Be Filed as Exhibits

Agreement Regarding Joint Filing of Statement on Schedule
13D or 13G.

Item 11. Certification.

By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.

Dated: January 25, 2016

STONEPINE CAPITAL, L.P.

By:  Stonepine Capital Management, LLC,
General Partner

By: /s/ Jon. M. Plexico
Managing Member

STONEPINE CAPITAL MANAGEMENT, LLC

By: /s/ Jon M. Plexico
Managing Member

/s/ Jon M. Plexico

/s/ Timothy P. Lynch

7

Follow Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)